IntervaOpen the desk

World Bank · Health

Algeria: Antiretroviral therapy coverage for PMTCT

74percent · 2019+131.3% since 2009

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT). Annual figures for Algeria from 2000 to 2019.

20002019

Every year

YearValue (percent)Note
201974
201870
201760
201650
201529
201432
201364
201242
201151
201053
200932
200837
20070
20060
20050
20040
20030
20020
20010
20000

Source

Published by World Bank, produced by UNAIDS. Licence: CC BY 4.0. Retrieved 2026-11-08.

The dataset for every country, with quality and provenance →

Cite or download

World Bank (2026). Antiretroviral therapy coverage for PMTCT. Interva. https://interva.co/dataset/worldbank-antiretroviral-therapy-coverage-for-pmtct (accessed 2026-11-15). catalog snapshot 2026-11-08.

JSON, AlgeriaAPI and MCP

Antiretroviral therapy coverage for PMTCT in other countries

Rank Algeria against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Algeria: Antiretroviral therapy coverage for PMTCT (2000–2019) · Interva